Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection

NCT00241670 is registered in ClinicalTrials.gov with medac GmbH as lead sponsor.

NCT NCT00241670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00241670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection
Lead sponsor
medac GmbH
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1999
Completion date
Not reported
Enrollment
415 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain tumor, primary, brain tumors, cancer of brain, primary brain tumors